Response to “Comment on: Botulinum Toxin Type A Overdoses: Analysis of the FDA Adverse Event Reporting System Database”.

HOME
>
論文・技術情報
>
Response to “Comment on: Botulinum Toxin Type A Overdoses: Analysis of the FDA Adverse Event Reporting System Database”.

アブストラクト
ジャーナル名	Clinical drug investigation
投稿日	2018/11/6
投稿者	Kazerooni, Rashid; Armstrong, Edward P
組織名	Medical Affairs, Merz North America, Inc., Raleigh, NC, USA.;rashid.kazerooni@merz.com.;Health Services Administration Graduate Program, University of Wyoming School of;Pharmacy, Laramie, WY, USA. rashid.kazerooni@merz.com.;Pharmacy, Laramie, WY, USA.
Pubmed リンク	https://www.ncbi.nlm.nih.gov/pubmed/30390199/

タグ:

お問合わせ

キーワード